Increased brain fatty acid uptake in metabolic syndrome

Diabetes

Volumn 59, Issue 9, 2010, Pages 2171-2177

  Karmi, Anna ^a   Iozzo, Patricia ^a,b   Viljanen, Antti ^a   Hirvonen, Jussi ^a   Fielding, Barbara A ^c   Virtanen, Kirsi ^a   Oikonen, Vesa ^a   Kemppainen, Jukka ^d   Viljanen, Tapio ^a   Guiducci, Letizia ^a,b   Haaparanta Solin, Merja ^a   Någren, Kjell ^e   Solin, Olof ^a   Nuutila, Pirjo ^a,d  

^a TURKU PET CENTRE   (Finland)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF TURKU   (Finland)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

6 THIAHEPTADECANOIC ACID F 18; FATTY ACID; FLUORINE 18; HEPTADECANOIC ACID; PALMITIC ACID C 11; UNCLASSIFIED DRUG; 14-FLUORO-6-THIAHEPTADECANOIC ACID; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FATTY ACID TRANSPORT; FEMALE; GRAY MATTER; HUMAN; LIPID BRAIN LEVEL; MALE; METABOLIC SYNDROME X; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; WEIGHT REDUCTION; WHITE MATTER; ANIMAL; BLOOD; BLOOD PRESSURE; BODY MASS; BRAIN; GLUCOSE TOLERANCE TEST; KINETICS; LOW CALORY DIET; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; REFERENCE VALUE; SWINE;

ADULT; ANIMALS; BLOOD PRESSURE; BODY MASS INDEX; BRAIN; CHOLESTEROL, LDL; DIET, REDUCING; FATTY ACIDS; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; KINETICS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; REFERENCE VALUES; SWINE; TRIGLYCERIDES;

EID: 77956363279     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db09-0138     Document Type: Article

References (31)

1. Obici S, Feng Z, Morgan K, Stein D, Karkanias G, Rossetti L. Central administration of oleic acid inhibits glucose production and food intake. Diabetes 2002;51:271-275
2. Lopez M, Lelliott CJ, Vidal-Puig A. Hypothalamic fatty acid metabolism: a housekeeping pathway that regulates food intake. Bioessays 2007;29:248-261
3. Lopez M, Lage R, Saha AK, Perez-Tilve D, Vazquez MJ, Varela L, Sangiao-Alvarellos S, Tovar S, Raghay K, Rodriguez-Cuenca S, Deoliveira RM, Castaneda T, Datta R, Dong JZ, Culler M, Sleeman MW, Alvarez CV, Gallego R, Lelliott CJ, Carling D, Tschop MH, Dieguez C, Vidal-Puig A. Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin. Cell Metab 2008;7:389-399
4. Lam TK, Schwartz GJ, Rossetti L. Hypothalamic sensing of fatty acids. Nat Neurosci 2005;8:579-584
5. Pocai A, Lam TK, Obici S, Gutierrez-Juarez R, Muse ED, Arduini A, Rossetti L. Restoration of hypothalamic lipid sensing normalizes energy and glucose homeostasis in overfed rats. J Clin Invest 2006;116:1081-1091
6. Miranda PJ, DeFronzo RA, Califf RM, Guyton JR. Metabolic syndrome: definition, pathophysiology, and mechanisms. Am Heart J 2005;149:33-45
7. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005;365:1415-1428
8. Morgan K, Obici S, Rossetti L. Hypothalamic responses to long-chain fatty acids are nutritionally regulated. J Biol Chem 2004;279:31139-31148
9. Arai T, Wakabayashi S, Channing MA, Dunn BB, Der MG, Bell JM, Herscovitch P, Eckelman WC, Rapoport SI, Chang MC. Incorporation of [1-carbon-11]palmitate in monkey brain using PET. J Nucl Med 1995;36:2261-2267
10. Kimes AS, Sweeney D, Rapoport SI. Brain palmitate incorporation in awake and anesthetized rats. Brain Res 1985;341:164-170
11. Miller JC, Gnaedinger JM, Rapoport SI. Utilization of plasma fatty acid in rat brain: distribution of [14C]palmitate between oxidative and synthetic pathways. J Neurochem 1987;49:1507-1514
12. Tabata H, Kimes AS, Robinson PJ, Rapoport SI. Stability of brain incorporation of plasma palmitate in unanesthetized rats of different ages, with appendix on palmitate model. Exp Neurol 1988;102:221-229
13. Knuuti J. Positron emission tomography-molecular imaging of biological processes. International Congress Series 2004;1265:248-254
14. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome - a new worldwide definition. Lancet 2005;366:1059-1062 (Pubitemid 41338752)
15. Padgett HC, Robinson GD, Barrio JR. [1-(11)C]palmitic acid: improved radiopharmaceutical preparation. Int J Appl Radiat Isot 1982;33:1471-1472
16. DeGrado TR, Coenen HH, Stocklin G. 14(R,S)-[18F]fluoro-6-thia- heptadecanoic acid (FTHA): evaluation in mouse of a new probe of myocardial utilization of long chain fatty acids. J Nucl Med 1991;32:1888-1896
17. DeGrado TR, Wang S, Holden JE, Nickles RJ, Taylor M, Stone CK. Synthesis and preliminary evaluation of (18)F-labeled 4-thia palmitate as a PET tracer of myocardial fatty acid oxidation. Nucl Med Biol 2000;27:221-231
18. Guiducci L, Gronroos T, Jarvisalo MJ, Kiss J, Viljanen A, Naum AG, Viljanen T, Savunen T, Knuuti J, Ferrannini E, Salvadori PA, Nuutila P, Iozzo P. Biodistribution of the fatty acid analogue 18F-FTHA: plasma and tissue partitioning between lipid pools during fasting and hyperinsulinemia. J Nucl Med 2007;48:455-462
19. Ebert A, Herzog H, Stocklin GL, Henrich MM, DeGrado TR, Coenen HH, Feinendegen LE. Kinetics of 14(R,S)-fluorine-18-fluoro-6-thia-heptadecanoic acid in normal human hearts at rest, during exercise and after dipyridamole injection. J Nucl Med 1994;35:51-56
20. Iozzo P, Turpeinen AK, Takala T, Oikonen V, Solin O, Ferrannini E, Nuutila P, Knuuti J. Liver uptake of free fatty acids in vivo in humans as determined with 14(R, S)-[18F]fluoro-6-thia-heptadecanoic acid and PET. Eur J Nucl Med Mol Imaging 2003;30:1160-1164
21. Takala TO, Nuutila P, Pulkki K, Oikonen V, Gronroos T, Savunen T, Vahasilta T, Luotolahti M, Kallajoki M, Bergman J, Forsback S, Knuuti J. 14(R,S)-[18F]Fluoro-6-thia-heptadecanoic acid as a tracer of free fatty acid uptake and oxidation in myocardium and skeletal muscle. Eur J Nucl Med Mol Imaging 2002;29:1617-1622
22. Robinson PJ, Noronha J, DeGeorge JJ, Freed LM, Nariai T, Rapoport SI. A quantitative method for measuring regional in vivo fatty-acid incorporation into and turnover within brain phospholipids: review and critical analysis. Brain Res Brain Res Rev 1992;17:187-214
23. Kimes AS, Sweeney D, London ED, Rapoport SI. Palmitate incorporation into different brain regions in the awake rat. Brain Res 1983;274:291-301
24. Gnaedinger JM, Miller JC, Latker CH, Rapoport SI. Cerebral metabolism of plasma [14C]palmitate in awake, adult rat: subcellular localization. Neurochem Res 1988;13:21-29
25. Robinson PJ, Rapoport SI. A method for examining turnover and synthesis of palmitate-containing brain lipids in vivo. Clin Exp Pharmacol Physiol 1989;16:701-714
26. Chang MC, Wakabayashi S, Bell JM. The effect of methyl palmoxirate on incorporation of [U-14C]palmitate into rat brain. Neurochem Res 1994;19:1217-1223
27. Chang MC, Grange E, Rabin O, Bell JM. Incorporation of [U-14C]palmitate into rat brain: effect of an inhibitor of beta-oxidation. J Lipid Res 1997;38:295-300
28. Haltia LT, Viljanen A, Parkkola R, Kemppainen N, Rinne JO, Nuutila P, Kaasinen V. Brain white matter expansion in human obesity and the recovering effect of dieting. J Clin Endocrinol Metab 2007;92:3278-3284
29. Pocai A, Obici S, Schwartz GJ, Rossetti L. A brain-liver circuit regulates glucose homeostasis. Cell Metab 2005;1:53-61
30. Shadid S, LaForge R, Otvos JD, Jensen MD. Treatment of obesity with diet/exercise versus pioglitazone has distinct effects on lipoprotein particle size. Atherosclerosis 2006;188:370-376
31. Haywood SC, Bree AJ, Puente E, Daphna-Iken D, Fisher SJ. Central, but not systemic lipid infusion, augments the counterregulatory response to hypoglycemia. Am J Physiol Endocrinol Metab 2009;297:E50-E56